Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Return on Assets (2016 - 2025)

Historic Return on Assets for Vanda Pharmaceuticals (VNDA) over the last 16 years, with Q4 2025 value amounting to 0.4%.

  • Vanda Pharmaceuticals' Return on Assets fell 3800.0% to 0.4% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.4%, marking a year-over-year decrease of 3800.0%. This contributed to the annual value of 0.39% for FY2025, which is 3600.0% down from last year.
  • According to the latest figures from Q4 2025, Vanda Pharmaceuticals' Return on Assets is 0.4%, which was down 3800.0% from 0.14% recorded in Q3 2025.
  • Vanda Pharmaceuticals' Return on Assets' 5-year high stood at 0.06% during Q3 2021, with a 5-year trough of 0.4% in Q4 2025.
  • For the 5-year period, Vanda Pharmaceuticals' Return on Assets averaged around 0.02%, with its median value being 0.01% (2022).
  • In the last 5 years, Vanda Pharmaceuticals' Return on Assets surged by 200bps in 2021 and then tumbled by -3800bps in 2025.
  • Over the past 5 years, Vanda Pharmaceuticals' Return on Assets (Quarter) stood at 0.06% in 2021, then crashed by -82bps to 0.01% in 2022, then plummeted by -61bps to 0.0% in 2023, then crashed by -847bps to 0.03% in 2024, then crashed by -1293bps to 0.4% in 2025.
  • Its Return on Assets was 0.4% in Q4 2025, compared to 0.14% in Q3 2025 and 0.11% in Q2 2025.